Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Neurosciences: Psychiatry

  • You have access
    In vivo serotonin transporter (SERT) availability in patients with first depressive episode (FDE)
    Anke Bresch, Swen Hesse, Julia Luthardt, Karsten Naegler, Peter Schoenknecht, Philipp Meyer, Georg-Alexander Becker, Marianne Patt, Ulrich Hegerl and Osama Sabri
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1295;
  • You have access
    The correlation between regional brain FDG metabolism and type A personality tendency
    Ilhan Lim, Sang Hee Kim, Hyun Soo Park, Ji Hee Hwang, Yu Kyeong Kim, Won Woo Lee and Sang Eun Kim
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1281;
  • You have access
    Cerebral blood flow distribution in autism spectrum disorder – A 11C – Butanol PET/CT study
    Irina Manouilenko, Sharon Stone-Elander, Richard Odh, Dario Salmaso, Anne-Marie Danielsson, Robert Hatherly, Hans Jacobsson, Stig Larsson, Susanne Bejerot and Marco Pagani
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1280;
  • You have access
    Reduced serotonin transporter binding in patients with major depression compared to healthy controls: A SPECT study
    Nancy Wintering, Jay Amsterdam, Emily Breslow and Andrew Newberg
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1296;
  • You have access
    Dopamine function during early withdrawal predicts recovery in methamphetamine users
    G-J Wang, L Smith, N Volkow, F Telang, J Logan, K Pradhan, W Hoffmann, D Tomasi, P Thanos and JS Fowler
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1284;
  • You have access
    Serotonin transporter (SERT) availability, body mass index (BMI) and depression
    Swen Hesse, Arno Villringer, Peter Schoenknecht, Georg-Alexander Becker, Marianne Patt, Anke Bresch, Julia Luthardt, Mathias Fasshauer and Osama Sabri
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1294;
  • You have access
    Contribution of SPECT measurements of D2 and 5HT2A receptor occupancy to the clinical development of the new antipsychotic SB-773812
    Ana Catafau, Santiago Bullich, Gianluca Nucci, Clare Burgess, Frank Gray and Emilio Merlo-Pich
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 313;
  • You have access
    Imaging pure dopamine D1 receptors with [11C]NNC112 PET and ketanserin challenge
    Ana Catafau, Graham Searle, Santiago Bullich, Roger N Gunn, Eugenii Rabiner, Raul Herance, Magi Farre and Marc Laruelle
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 308;
  • You have access
    Imaging reward function in healthy volunteers with PET and fMRI
    Nina Urban, Yongxia Zhou, Xiaoyan Xu, Rawad Ayoub, Mark Slifstein, Godfrey Pearlson, John Krystal and Anissa Abi-Dargham
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 309;
  • You have access
    Effects of antipsychotic drug on dopamine synthesis in humans measured by PET with [C-11]DOPA
    Hiroshi Ito, Harumasa Takano, Hidehiko Takahashi, Ryosuke Arakawa and Tetsuya Suhara
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 307;

Pages

  • Previous
  • Next
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 14
SNMMI

© 2025 SNMMI

Powered by HighWire